Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -15.31%5.78M | -27.17%4.62M | -45.26%1.72M | 22.61%23.17M | 13.72%6.87M | 1.37%6.83M | 92.79%6.34M | 10.67%3.13M | -29.93%18.9M | 10.01%6.04M |
| Cost of revenue | 14.44%18.21M | -17.55%15.92M | ||||||||
| Gross profit | -45.26%1.72M | 66.30%4.95M | 3.13M | -61.11%2.98M | ||||||
| Operating expense | -11.08%5.44M | -20.65%4.7M | -35.22%2.51M | -0.38%6.79M | 0.72%8.91M | -6.00%6.12M | 48.16%5.92M | 14.79%3.88M | 40.25%6.82M | 169.78%8.84M |
| Selling and administrative expenses | ---- | ---- | ---- | 5.62%4.3M | ---- | ---- | ---- | ---- | 0.84%4.07M | ---- |
| -General and administrative expense | ---- | ---- | ---- | 5.62%4.3M | ---- | ---- | ---- | ---- | 0.84%4.07M | ---- |
| Other operating expenses | -11.08%5.44M | -20.65%4.7M | -35.22%2.51M | -9.30%2.49M | 0.72%8.91M | -6.00%6.12M | 48.16%5.92M | 14.79%3.88M | 234.39%2.74M | 152.91%8.84M |
| Total other operating income | ---- | ---- | 284.85%381K | ---- | ---- | ---- | ---- | --99K | ---- | ---- |
| Operating profit | -52.13%337K | -119.05%-80K | -6.82%-799K | 52.15%-1.84M | 27.31%-2.04M | 218.55%704K | 159.41%420K | -36.00%-748K | -236.99%-3.84M | -145.92%-2.8M |
| Net non-operating interest income (expenses) | 25.00%-3K | 25.00%-3K | 40.00%-3K | -47.19%94K | 50.00%-6K | 33.33%-4K | 33.33%-4K | 28.57%-5K | 165.67%178K | -115.79%-12K |
| Non-operating interest income | ---- | ---- | ---- | -45.67%113K | ---- | ---- | ---- | ---- | 121.28%208K | ---- |
| Non-operating interest expense | -25.00%3K | -25.00%3K | -40.00%3K | -36.67%19K | -50.00%6K | -33.33%4K | -33.33%4K | -28.57%5K | 11.11%30K | -33.33%12K |
| Net investment income | 1,411.11%136K | -99.89%9K | ||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -87.50%2K | -44.83%16K | ||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 34,700.00%348K | -80.00%1K | ||||||||
| Less:Other special charges | ---- | ---- | ---- | -14,700.00%-148K | ---- | ---- | ---- | ---- | ---1K | ---- |
| Less:Write off | ---- | ---- | ---- | ---200K | ---- | ---- | ---- | ---- | --0 | ---- |
| Other non-operating income (expenses) | -55.29%76K | 6.19%103K | 284.85%381K | 18.17%852K | 85.96%1.09M | -3.41%170K | -2.02%97K | 4.21%99K | 83.93%721K | 184.88%584K |
| Income before tax | -52.87%410K | -96.10%20K | 35.63%-421K | 86.13%-404K | 57.11%-956K | 122.51%870K | 183.55%513K | -41.56%-654K | -125.94%-2.91M | -131.37%-2.23M |
| Income tax | -30.55%191K | 0 | 0 | 91.54%-46K | 22.63%-424K | 9,066.67%275K | 102K | 0 | -154.67%-544K | -267.79%-548K |
| Net income | -63.19%219K | -95.13%20K | 35.63%-421K | 84.88%-358K | 68.35%-532K | 53.35%595K | 166.94%411K | -41.56%-654K | -123.15%-2.37M | -123.17%-1.68M |
| Net income continuous operations | -63.19%219K | -95.13%20K | 35.63%-421K | 84.88%-358K | 68.35%-532K | 53.35%595K | 166.94%411K | -41.56%-654K | -123.15%-2.37M | -123.17%-1.68M |
| Noncontrolling interests | 58.82%-7K | 50.00%-5K | 36.67%-19K | 115.44%23K | 174.07%80K | -54.55%-17K | -25.00%-10K | -30.43%-30K | -104.85%-149K | -103.46%-108K |
| Net income attributable to the company | -63.07%226K | -94.06%25K | 35.58%-402K | 82.83%-381K | 61.09%-612K | 53.38%612K | 169.47%421K | -42.14%-624K | -131.00%-2.22M | -138.01%-1.57M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -63.07%226K | -94.06%25K | 35.58%-402K | 82.83%-381K | 61.09%-612K | 53.38%612K | 169.47%421K | -42.14%-624K | -131.00%-2.22M | -138.01%-1.57M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -63.77%0.0025 | -93.62%0.0003 | 35.71%-0.0045 | 82.73%-0.0043 | 61.02%-0.0069 | 53.33%0.0069 | 169.12%0.0047 | -42.86%-0.007 | -130.97%-0.0249 | -138.06%-0.0177 |
| Diluted earnings per share | -63.77%0.0025 | -93.62%0.0003 | 35.71%-0.0045 | 82.73%-0.0043 | 61.02%-0.0069 | 53.33%0.0069 | 169.12%0.0047 | -42.86%-0.007 | -130.97%-0.0249 | -138.09%-0.0177 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.